The primary medication used to manage benzodiazepine withdrawal is, perhaps surprisingly, another benzodiazepine. A longer-acting one like diazepam is substituted for whatever shorter-acting drug you’ve been taking, then gradually tapered down over weeks or months. Beyond that core strategy, a handful of other medications can help with specific symptoms or reduce the severity of the process overall.
Why a Gradual Taper Is the Foundation
Stopping benzodiazepines abruptly is dangerous. In one hospital review, seizures occurred in 10% of cases involving acute benzodiazepine withdrawal. The standard approach is a slow, controlled dose reduction rather than quitting cold turkey. There is no single standard tapering schedule. The rate depends on how much you’ve been taking, how long you’ve been on the medication, and how your body responds as the dose drops.
The most common method is switching from a short-acting benzodiazepine (like alprazolam or lorazepam) to a longer-acting one (like diazepam). Longer-acting drugs produce smoother, more gradual changes in your blood levels, which makes the step-down less jarring to your nervous system. From there, the dose is reduced in small increments. This process often takes several weeks and sometimes stretches to months for people who have been on high doses or have used benzodiazepines for years.
Combining gradual dose reduction with psychological support, particularly cognitive behavioral therapy, improves outcomes compared to tapering alone. A meta-analysis found the combination was more effective, though evidence remains moderate rather than overwhelming.
Anticonvulsants: Carbamazepine and Pregabalin
Anticonvulsant medications are the best-supported add-on option during a benzodiazepine taper. They work on some of the same brain pathways that become overexcited during withdrawal, helping to calm that rebound activity.
Carbamazepine has a modest but real benefit in reducing withdrawal symptoms, provided you aren’t also dependent on other substances. It’s one of the better-studied options and has enough data behind it that clinicians use it with reasonable confidence. Pregabalin, which reduces nerve signaling involved in anxiety and pain, has also shown effectiveness during benzodiazepine withdrawal. Both medications can help take the edge off the anxiety, agitation, and sensory disturbances that make the taper process so difficult.
Valproate, another anticonvulsant sometimes used for alcohol withdrawal, does not appear to help with benzodiazepine withdrawal specifically. Not all anticonvulsants are interchangeable here.
Gabapentin: Limited Evidence So Far
Gabapentin gets a lot of attention in online discussions about withdrawal support, and it does work on similar brain chemistry as pregabalin. However, the research specifically supporting gabapentin for benzodiazepine withdrawal is thin. Most of the existing studies looked at gabapentin for alcohol withdrawal rather than benzodiazepine withdrawal, and even in that context, a systematic review concluded there was insufficient evidence to recommend widespread use. The studies that do exist are mostly retrospective with a high risk of confounding factors.
That doesn’t mean gabapentin is useless, but it does mean its role in benzodiazepine withdrawal is based more on clinical experience and its pharmacological similarity to pregabalin than on strong direct evidence.
Flumazenil: A Specialized Option
Flumazenil works directly on the same brain receptors that benzodiazepines bind to, acting as a partial activator that can essentially “reset” those receptors. Preliminary data suggest that a continuous low-dose infusion given over four days can significantly reduce acute withdrawal symptoms, either alongside a taper or as a way to move more quickly to a lower dose or full abstinence.
This treatment is administered intravenously or under the skin and requires medical supervision in a clinical setting. It’s not widely available and is typically reserved for cases where conventional tapering has failed or is impractical. The research is promising but still preliminary, and access to this treatment varies significantly depending on where you live.
Medications for Specific Symptoms
Withdrawal from benzodiazepines produces a constellation of symptoms: insomnia, anxiety, muscle tension, heightened sensory sensitivity, depression, and sometimes involuntary muscle jerks. Some medications can target these individual symptoms even if they don’t address the underlying withdrawal process.
Mirtazapine, an antidepressant with strong sedating properties, has shown some promise for the insomnia and depression that commonly emerge during withdrawal. In at least one documented case, it also helped with sleep-related muscle jerking (myoclonus) that was linked to the withdrawal process. However, this evidence comes from case reports rather than large trials, so it remains an off-label, experimental use.
Antidepressants and beta-blockers as broader classes have no proven benefit for benzodiazepine withdrawal overall. Beta-blockers can lower heart rate and reduce tremor, which might provide comfort, but they don’t address the core withdrawal syndrome. If your clinician prescribes one of these, it’s likely targeting a specific symptom rather than treating the withdrawal itself.
Protracted Withdrawal and Long-Term Symptoms
For some people, withdrawal symptoms don’t end when the taper does. Symptoms in the first week after stopping tend to merge with more persistent problems that can last for months. These prolonged symptoms often include anxiety, sensory disturbances (like tingling, numbness, or hypersensitivity to light and sound), and motor symptoms. Researchers note it’s difficult to draw a precise line around how long withdrawal lasts, because these lingering effects may not be classical pharmacological withdrawal but are still clearly related to long-term benzodiazepine use.
The possibility that prolonged benzodiazepine use may cause slowly reversible changes in the nervous system, and in rare cases potentially lasting structural changes, underscores why the taper process matters. A well-managed, gradual withdrawal gives your brain time to readjust. Medications used during the acute phase may not be needed long-term, but some people find that ongoing support for anxiety or sleep (through non-benzodiazepine options and therapy) helps during the months of recovery that follow.
What Actually Works Best
The honest picture is that research on benzodiazepine withdrawal management is surprisingly limited. Practice is guided more by general principles than by large, rigorous trials. What the available evidence does support is a clear hierarchy: a gradual taper using a long-acting benzodiazepine is the backbone, anticonvulsants like carbamazepine or pregabalin can meaningfully help as add-ons, and everything else falls into the category of symptom management or experimental treatment.
The most important factor may not be which specific medication you use but how the process is structured. A taper that’s too fast will cause unnecessary suffering and risk seizures. One that’s appropriately paced, adjusted based on your response, and paired with psychological support gives you the best chance of getting through it safely.